VIVOLTA
is a Private company. Denis Leissing is the CEO of VIVOLTA . VIVOLTA 's latest funding round was a Equity for $7.5M on Jun 2023. VIVOLTA has 1 followers on Owler.VIVOLTA
is a Private company. Denis Leissing is the CEO of VIVOLTA . VIVOLTA 's latest funding round was a Equity for $7.5M on Jun 2023. VIVOLTA has 1 followers on Owler.
News
Nov 03, 2025
StreetInsider
Press Release: VIVOLTA : VIVOLTA expands regenerative implant manufacturing capability with dedicated facility
Aug 07, 2025
FinanzNachrichten
VIVOLTA : VIVOLTA and Fibrothelium partner to manufacture SimplySilk membrane for Guided Bone Regeneration
Nov 13, 2024
PharmaTimes
VIVOLTA : Vivolta and Neurochase to produce brain therapy catheters
Aug 01, 2024
Medical Product Outsourcing
VIVOLTA : Didier Deltort Joins Vivolta B.V.'s Supervisory Board
Nov 30, 2023
FinanzNachrichten
VIVOLTA : VIVOLTA Strengthens Leadership Team With New CEO and New Chairman to Drive Next Phase of Growth
Oct 26, 2023
Business Wire
Press Release: VIVOLTA : Avelo, VIVOLTA, and BLINK Win 1.5M Eurostars Grant to Develop New Solution for Diagnosing Lower Respiratory Tract Infections
Jun 13, 2023
FinSMEs
VIVOLTA : Vivolta Raises 7M in Funding
Jun 13, 2023
FinanzNachrichten
VIVOLTA : VIVOLTA Raises 7 Million Financing to Further Execute Its Growth Strategy as Medical Electrospinning CDMO
May 27, 2021
Markets Insider
VIVOLTA : IME Medical Electrospinning helps shape the first standard on fiber-based medical scaffolds, published by ASTM International
Feb 11, 2021
NS Medical Devices
VIVOLTA : IME Medical Electrospinning and STENTiT enter into development cooperation on resorbable endovascular support grafts to regenerate vascular tissue